Kedi is developing
human-grade therapies for pets

A person petting a tabby cat with closed eyes on a bed of fallen autumn leaves.

Committed to Animal Health

Veterinary medicine lags decades behind humans. Personal experience with this gap is what motivates us to close it.

Kedi is a startup focused on advancing the veterinary application of drug mechanisms which revolutionized care of challenging human diseases.

We discover novel biologic molecules and specifically tailor them to cats. Kedi’s fully feline drug candidates aim to give veterinarians the precision arsenal they need to treat life-threatening and chronic diseases.

Kedi builds safe and efficacious alternatives at the cost of current care.

A tabby cat walking along a concrete ledge near a harbor with boats, water, and distant buildings under a cloudy sky.

Biologic therapies can combat many human diseases. We’re giving cats the same chance.

A close-up of two cats cuddling and sleeping together on a concrete surface, with one ginger and one light-colored cat.

We are using advanced biotech tools to better understand cat biology.